Quick Answer
Solventum Corp reported Research And Development Expense of $739.00 million for the year ending 2025.
- Solventum Corp showed a decrease of -4.6% in Research And Development Expense from 2024 to 2025.
- This data is from Solventum Corp's annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2023: $195.00 million | Q2 2023: $193.00 million | Q3 2023: $180.00 million | Q1 2024: $195.00 million | Q2 2024: $192.00 million | Q3 2024: $189.00 million | Q1 2025: $193.00 million | Q2 2025: $189.00 million | Q3 2025: $183.00 million.
- Over the full 4 years of available data (2022 to 2025), Solventum Corp's Research And Development Expense has declined by 3.7%.
- Historical annual values: Fiscal year 2025: $739.00 million | Fiscal year 2024: $775.00 million | Fiscal year 2023: $758.00 million | Fiscal year 2022: $767.00 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: